Universidad Nacional de La Plata Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00799916
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Facultad de Ciencias Exactas, Universidad Nacional de La Plata

Active Ingredients

Drugs in Phase 3 Trials (2)

hydroxyethyl starch (voluven) (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (1)

benznidazole (Rochagan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sepsis (Phase 3)

Toxemia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3